Search research articles
Contact Us
Filters
Showing results (51-60 of 394) with videos related to
Page
of 40
Sort By:
Journal of Neural Transmission. Supplementum
|
August 30, 2003
Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease
M Gerlach, K Double, H Reichmann, et al.
Organic & Biomolecular Chemistry
|
October 18, 2018
Next generation diversity-oriented synthesis: a paradigm shift from chemical diversity to biological diversity
Ivan Pavlinov, Erica M Gerlach, Leslie N Aldrich
European Journal of Neurology
|
February 3, 2011
Antioxidative properties of aspirin: dose dependence and clinical implications
W Kuhn, T Müller, T Büttner, et al.
Advances in Neurology
|
July 20, 1999
Role of iron in 6-hydroxydopamine neurotoxicity
K L Double, P F Riederer, M Gerlach
Fortschritte Der Medizin
|
November 30, 1995
[Acetylsalicylic acid as free radical scavenger. An argument for increased dosages in acute and preventive therapy of vascular diseases]
W Kuhn, T Müller, T Büttner, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
September 13, 2023
The PATCH-Trauma Trial: Antifibrinolytics and Stanching the Blood Meridian in Trauma
Rebecca M Gerlach, Neal S Gerstein, Isaac Tawil
Stroke
|
October 1, 1995
Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia
W Kuhn, T Müller, T Bttner, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1988
Pharmacokinetic studies with sustained-release formulations of levodopa in healthy volunteers
M Gerlach, B Gebhardt, W Kuhn, et al.
Journal of Neural Transmission. Supplementum
|
November 7, 2007
Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis
F Tribl, T Arzberger, P Riederer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 13, 2007
Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate
H Stopper, S Walitza, A Warnke, et al.
Page
of 40
Search research articles
Search
Showing results (51-60 of 394) with videos related to
Sort By:
Page
of 40
Journal of Neural Transmission. Supplementum
|
August 30, 2003
Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease
M Gerlach, K Double, H Reichmann, et al.
Organic & Biomolecular Chemistry
|
October 18, 2018
Next generation diversity-oriented synthesis: a paradigm shift from chemical diversity to biological diversity
Ivan Pavlinov, Erica M Gerlach, Leslie N Aldrich
European Journal of Neurology
|
February 3, 2011
Antioxidative properties of aspirin: dose dependence and clinical implications
W Kuhn, T Müller, T Büttner, et al.
Advances in Neurology
|
July 20, 1999
Role of iron in 6-hydroxydopamine neurotoxicity
K L Double, P F Riederer, M Gerlach
Fortschritte Der Medizin
|
November 30, 1995
[Acetylsalicylic acid as free radical scavenger. An argument for increased dosages in acute and preventive therapy of vascular diseases]
W Kuhn, T Müller, T Büttner, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
September 13, 2023
The PATCH-Trauma Trial: Antifibrinolytics and Stanching the Blood Meridian in Trauma
Rebecca M Gerlach, Neal S Gerstein, Isaac Tawil
Stroke
|
October 1, 1995
Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia
W Kuhn, T Müller, T Bttner, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1988
Pharmacokinetic studies with sustained-release formulations of levodopa in healthy volunteers
M Gerlach, B Gebhardt, W Kuhn, et al.
Journal of Neural Transmission. Supplementum
|
November 7, 2007
Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis
F Tribl, T Arzberger, P Riederer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 13, 2007
Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate
H Stopper, S Walitza, A Warnke, et al.
Page
of 40